Global N-acetylaspartate concentration in benign and non-benign multiple sclerosis patients of long disease duration
about
The Utility of Magnetic Resonance Spectroscopy for Understanding Substance Use Disorders: A Systematic Review of the LiteratureAutomated whole-brain N-acetylaspartate proton MRS quantification.Reduced gamma-aminobutyric acid concentration is associated with physical disability in progressive multiple sclerosis.A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause?
P2860
Global N-acetylaspartate concentration in benign and non-benign multiple sclerosis patients of long disease duration
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Global N-acetylaspartate conce ...... ients of long disease duration
@en
Global N-acetylaspartate conce ...... ents of long disease duration.
@nl
type
label
Global N-acetylaspartate conce ...... ients of long disease duration
@en
Global N-acetylaspartate conce ...... ents of long disease duration.
@nl
prefLabel
Global N-acetylaspartate conce ...... ients of long disease duration
@en
Global N-acetylaspartate conce ...... ents of long disease duration.
@nl
P2093
P2860
P50
P1476
Global N-acetylaspartate conce ...... ients of long disease duration
@en
P2093
Achim Gass
Daniel J Rigotti
Iris-Katharina Penner
James S Babb
Jochen Hirsch
Kerstin Bendfeldt
Lutz Achtnichts
Michael Amann
Yvonne Naegelin
P2860
P304
P356
10.1016/J.EJRAD.2013.08.037
P577
2013-09-04T00:00:00Z